83 related articles for article (PubMed ID: 20978525)
1. Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects.
Schwab U; Alfthan G; Aro A; Uusitupa M
Eur J Clin Nutr; 2011 Jan; 65(1):70-6. PubMed ID: 20978525
[TBL] [Abstract][Full Text] [Related]
2. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.
Kilic S; Yilmaz N; Erdogan G; Aydin M; Tasdemir N; Doganay M; Batioglu S
Climacteric; 2010 Feb; 13(1):55-62. PubMed ID: 19591007
[TBL] [Abstract][Full Text] [Related]
3. Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated.
Lever M; Slow S; George PM; Chambers ST
Clin Biochem; 2012 Jan; 45(1-2):154-6. PubMed ID: 22093969
[TBL] [Abstract][Full Text] [Related]
4. Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males.
Atkinson W; Slow S; Elmslie J; Lever M; Chambers ST; George PM
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):767-73. PubMed ID: 19346114
[TBL] [Abstract][Full Text] [Related]
5. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein in metabolic syndrome.
Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
[TBL] [Abstract][Full Text] [Related]
7. Betaine supplementation and the metabolic syndrome.
Slow S; Lever M; Elmslie J
Eur J Clin Nutr; 2011 Jun; 65(6):771; author reply 772. PubMed ID: 21427745
[No Abstract] [Full Text] [Related]
8. [Homocystein serum levels and lipid parameters in children with atherosclerosis risk factors].
Sierakowska-Fijałek A; Kaczmarek P; Pokoca L; Smorag I; Wosik-Erenbek M; Baj Z
Pol Merkur Lekarski; 2007 Feb; 22(128):146-9. PubMed ID: 17598661
[TBL] [Abstract][Full Text] [Related]
9. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
Piolot A; Blache D; Boulet L; Fortin LJ; Dubreuil D; Marcoux C; Davignon J; Lussier-Cacan S
J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.
Glew RH; Conn CA; Vanderjagt TA; Calvin CD; Obadofin MO; Crossey M; Vanderjagt DJ
J Health Popul Nutr; 2004 Dec; 22(4):357-69. PubMed ID: 15663169
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine increases the risk associated with hyperlipidaemia.
Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
[TBL] [Abstract][Full Text] [Related]
12. Heritability of metabolic syndrome traits among healthy younger adults: a population based study in China.
Luo BF; Du L; Li JX; Pan BY; Xu JM; Chen J; Yin XY; Ren Y; Zhang F
J Med Genet; 2010 Jun; 47(6):415-20. PubMed ID: 19755428
[TBL] [Abstract][Full Text] [Related]
13. Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts.
Pereska ZJ; Bozinovska C; Dimitrovski C; Petkovska L; Cibisev A; Jurukov I
Am J Drug Alcohol Abuse; 2011 May; 37(3):196-202. PubMed ID: 21453194
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria.
Glew RH; Kassam HA; Bhanji RA; Okorodudu A; VanderJagt DJ
J Health Popul Nutr; 2002 Jun; 20(2):166-74. PubMed ID: 12186197
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse.
Lohe VK; Degwekar SS; Bhowate RR; Kadu RP; Dangore SB
J Oral Pathol Med; 2010 Feb; 39(2):141-8. PubMed ID: 20002982
[TBL] [Abstract][Full Text] [Related]
17. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome.
Casella-Filho A; Chagas AC; Maranhão RC; Trombetta IC; Cesena FH; Silva VM; Tanus-Santos JE; Negrão CE; da Luz PL
Am J Cardiol; 2011 Apr; 107(8):1168-72. PubMed ID: 21310370
[TBL] [Abstract][Full Text] [Related]
18. Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.
Söderlund S; Watanabe H; Ehnholm C; Jauhiainen M; Taskinen MR
Metabolism; 2010 Oct; 59(10):1502-9. PubMed ID: 20206948
[TBL] [Abstract][Full Text] [Related]
19. Is plasma homocysteine level associated with metabolic syndrome components in adolescents?
Budak N; Yazici C; Oztürk A; Bayram F; Mazicioğlu MM; Kurtoglu S
Metab Syndr Relat Disord; 2009 Aug; 7(4):357-62. PubMed ID: 19558275
[TBL] [Abstract][Full Text] [Related]
20. Variations on cardiovascular risk factors in metabolic syndrome after consume of a citrus-based juice.
Mulero J; Bernabé J; Cerdá B; García-Viguera C; Moreno DA; Albaladejo MD; Avilés F; Parra S; Abellán J; Zafrilla P
Clin Nutr; 2012 Jun; 31(3):372-7. PubMed ID: 22197455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
